Pitcairn Co. Sells 17 Shares of MSCI Inc. (NYSE:MSCI)

Pitcairn Co. decreased its stake in shares of MSCI Inc. (NYSE:MSCI) by 1.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 901 shares of the technology company’s stock after selling 17 shares during the period. Pitcairn Co.’s holdings in MSCI were worth $525,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Rothschild Investment LLC bought a new stake in shares of MSCI during the second quarter worth approximately $26,000. HWG Holdings LP acquired a new stake in MSCI during the 2nd quarter worth approximately $27,000. Ashton Thomas Securities LLC bought a new stake in MSCI in the 3rd quarter valued at $40,000. Planning Capital Management Corp grew its holdings in MSCI by 35.1% in the 3rd quarter. Planning Capital Management Corp now owns 77 shares of the technology company’s stock valued at $45,000 after buying an additional 20 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new position in MSCI during the 2nd quarter worth $40,000. Institutional investors and hedge funds own 89.97% of the company’s stock.

Analysts Set New Price Targets

MSCI has been the topic of several research reports. Redburn Atlantic upgraded shares of MSCI from a “neutral” rating to a “buy” rating and set a $680.00 price target on the stock in a research note on Wednesday, October 9th. Barclays increased their target price on shares of MSCI from $650.00 to $700.00 and gave the stock an “overweight” rating in a research report on Friday, September 13th. Evercore ISI assumed coverage on MSCI in a research report on Wednesday, October 2nd. They set an “outperform” rating and a $690.00 price target on the stock. Wells Fargo & Company lifted their price objective on MSCI from $570.00 to $600.00 and gave the company an “equal weight” rating in a report on Friday, October 11th. Finally, UBS Group cut their target price on MSCI from $695.00 to $680.00 and set a “buy” rating for the company in a research report on Wednesday, October 30th. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, MSCI currently has an average rating of “Moderate Buy” and an average target price of $631.83.

MSCI Trading Up 0.5 %

MSCI opened at $592.70 on Tuesday. The company has a market cap of $46.45 billion, a P/E ratio of 38.92, a PEG ratio of 3.06 and a beta of 1.11. The company’s 50 day moving average is $586.91 and its 200-day moving average is $543.26. MSCI Inc. has a 1-year low of $439.95 and a 1-year high of $631.70.

MSCI (NYSE:MSCI) last issued its earnings results on Tuesday, October 29th. The technology company reported $3.86 earnings per share for the quarter, beating analysts’ consensus estimates of $3.77 by $0.09. The firm had revenue of $724.70 million for the quarter, compared to analyst estimates of $716.15 million. MSCI had a net margin of 43.06% and a negative return on equity of 162.06%. The company’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the business posted $3.45 earnings per share. On average, equities analysts forecast that MSCI Inc. will post 14.98 EPS for the current year.

MSCI Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be issued a $1.60 dividend. The ex-dividend date is Friday, November 15th. This represents a $6.40 dividend on an annualized basis and a yield of 1.08%. MSCI’s payout ratio is presently 42.02%.

MSCI Profile

MSCI Inc, together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.